Maverick Therapeutics

About:

Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers

Website: https://www.mavericktx.com/

Top Investors: Takeda, MPM Capital

Description:

Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRA™, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

Total Funding Amount:

$125M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brisbane, California, United States

Founded Date:

2016-01-01

Founders:

Jeanmarie Guenot

Number of Employees:

10001+

Last Funding Date:

2017-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai